UB Paderborn / Katalog / Suche / in CDI

Dysregulation of Mucosal Membrane Transporters and Drug-Metabolizing Enzymes in Ulcerative Colitis

Journal of pharmaceutical sciences, 2019-02, Vol.108 (2), p.1035-1046

2019

Volltextzugriff (PDF)

Down-regulation of ATP-binding cassette C2 protein expression in HepG2 cells after rifampicin treatment is mediated by microRNA-379

Molecular pharmacology, 2011-08, Vol.80 (2), p.314-320

2011

Volltextzugriff (PDF)

Expression differences of miR-142-5p between treatment-naïve chronic myeloid leukemia patients responding and non-responding to imatinib therapy suggest a link to oncogenic ABL2, SRI, cKIT and MCL1 signaling pathways critical for development of therapy resistance

Experimental hematology & oncology, 2020-09, Vol.9 (1), p.26-26, Article 26

2020

Volltextzugriff (PDF)

Transient receptor potential channel polymorphisms are associated with the somatosensory function in neuropathic pain patients

PloS one, 2011-03, Vol.6 (3), p.e17387-e17387

2011

Volltextzugriff (PDF)

SOX11 identified by target gene evaluation of miRNAs differentially expressed in focal and non-focal brain tissue of therapy-resistant epilepsy patients

Neurobiology of disease, 2015-05, Vol.77, p.127-140

2015

Volltextzugriff (PDF)

Influence of genetic polymorphisms on intestinal expression and rifampicin-type induction of ABCC2 and on bioavailability of talinolol

Pharmacogenetics and genomics, 2008-04, Vol.18 (4), p.357-365

2008

Volltextzugriff (PDF)

Variable expression of MRP2 (ABCC2) in human placenta: influence of gestational age and cellular differentiation

Drug metabolism and disposition, 2005-07, Vol.33 (7), p.896

2005

Volltextzugriff (PDF)

Biodistribution and pharmacokinetics of the 99mTc labeled human elastase inhibitor, elafin, in rats

Drug metabolism and pharmacokinetics, 2016-04, Vol.31 (2), p.146-155

2016

Volltextzugriff (PDF)

MicroRNAs and their relevance to ABC transporters

British journal of clinical pharmacology, 2014-04, Vol.77 (4), p.587-596

2014

Volltextzugriff (PDF)

miRNAs as mediators of drug resistance

Epigenomics, 2012-08, Vol.4 (4), p.369-381

2012

Volltextzugriff (PDF)

Genotype Frequencies of Selected Drug Metabolizing Enzymes and ABC Drug Transporters among Breast Cancer Patients on FAC Chemotherapy

Basic & clinical pharmacology & toxicology, 2010-07, Vol.107 (1), p.570-576

2010

Volltextzugriff (PDF)

MicroRNA profiling in K-562 cells under imatinib treatment: influence of miR-212 and miR-328 on ABCG2 expression

Pharmacogenetics and genomics, 2012-03, Vol.22 (3), p.198-205

2012

Volltextzugriff (PDF)

Length variants of the ABCB1 3'-UTR and loss of miRNA binding sites: possible consequences in regulation and pharmacotherapy resistance

Pharmacogenomics, 2016-03, Vol.17 (4), p.327-340

2016

Volltextzugriff (PDF)

Clinically Relevant Multidrug Transporters Are Regulated by microRNAs along the Human Intestine

Molecular pharmaceutics, 2017-07, Vol.14 (7), p.2245-2253

2017

Volltextzugriff (PDF)

Genetic variants may play an important role in mRNA–miRNA interaction: evidence for haplotype-dependent downregulation of ABCC2 (MRP2) by miRNA-379

Pharmacogenetics and genomics, 2014-06, Vol.24 (6), p.283-291

2014

Volltextzugriff (PDF)

MicroRNA-212/ABCG2-axis contributes to development of imatinib-resistance in leukemic cells

Oncotarget, 2017-11, Vol.8 (54), p.92018-92031

2017

Volltextzugriff (PDF)

Micro RNA s and their relevance to ABC transporters

British journal of clinical pharmacology, 2014-04, Vol.77 (4), p.587-596

2014

Volltextzugriff (PDF)

Cyclophosphamide treatment-induced leukopenia rates in ANCA-associated vasculitis are influenced by variant CYP450 2C9 genotypes

Pharmacogenomics, 2016-03, Vol.17 (4), p.367-374

2016

Volltextzugriff (PDF)

SIGMA-1 Receptor Gene Variants Affect the Somatosensory Phenotype in Neuropathic Pain Patients

The journal of pain, 2019-02, Vol.20 (2), p.201-214

2019

Volltextzugriff (PDF)

Impact of ABCC2 genotype on antiepileptic drug response in Caucasian patients with childhood epilepsy

Pharmacogenetics and genomics, 2011-10, Vol.21 (10), p.624-630

2011

Volltextzugriff (PDF)

Non-response to antiepileptic pharmacotherapy is associated with the ABCC2 −24C>T polymorphism in young and adult patients with epilepsy

Pharmacogenetics and genomics, 2009-05, Vol.19 (5), p.353-362

2009

Volltextzugriff (PDF)

Association of ATP-binding cassette transporter variants with the risk of Alzheimer's disease

Pharmacogenomics, 2013-04, Vol.14 (5), p.485-494

2013

Volltextzugriff (PDF)

Length variants of the

Pharmacogenomics, 2016-03, Vol.17 (4), p.327-340

2016

Volltextzugriff (PDF)

miRNA-187-3p-Mediated Regulation of the KCNK10/TREK‑2 Potassium Channel in a Rat Epilepsy Model

ACS chemical neuroscience, 2016-11, Vol.7 (11), p.1585-1594

2016

Volltextzugriff (PDF)

Expression of drug metabolizing enzymes along the human gastrointestinal tract

Pharmacological reports, 2015-09, Vol.67, p.21-21

2015

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Dysregulation of Mucosal Membrane Transporters and Drug-Metabolizing Enzymes in Ulcerative Colitis

Down-regulation of ATP-binding cassette C2 protein expression in HepG2 cells after rifampicin treatment is mediated by microRNA-379

Expression differences of miR-142-5p between treatment-naïve chronic myeloid leukemia patients responding and non-responding to imatinib therapy suggest a link to oncogenic ABL2, SRI, cKIT and MCL1 signaling pathways critical for development of therapy resistance

Transient receptor potential channel polymorphisms are associated with the somatosensory function in neuropathic pain patients

SOX11 identified by target gene evaluation of miRNAs differentially expressed in focal and non-focal brain tissue of therapy-resistant epilepsy patients

Influence of genetic polymorphisms on intestinal expression and rifampicin-type induction of ABCC2 and on bioavailability of talinolol

Variable expression of MRP2 (ABCC2) in human placenta: influence of gestational age and cellular differentiation

Biodistribution and pharmacokinetics of the 99mTc labeled human elastase inhibitor, elafin, in rats

MicroRNAs and their relevance to ABC transporters

miRNAs as mediators of drug resistance

Genotype Frequencies of Selected Drug Metabolizing Enzymes and ABC Drug Transporters among Breast Cancer Patients on FAC Chemotherapy

MicroRNA profiling in K-562 cells under imatinib treatment: influence of miR-212 and miR-328 on ABCG2 expression

Length variants of the ABCB1 3'-UTR and loss of miRNA binding sites: possible consequences in regulation and pharmacotherapy resistance

Clinically Relevant Multidrug Transporters Are Regulated by microRNAs along the Human Intestine

Genetic variants may play an important role in mRNA–miRNA interaction: evidence for haplotype-dependent downregulation of ABCC2 (MRP2) by miRNA-379

MicroRNA-212/ABCG2-axis contributes to development of imatinib-resistance in leukemic cells

Micro RNA s and their relevance to ABC transporters

Cyclophosphamide treatment-induced leukopenia rates in ANCA-associated vasculitis are influenced by variant CYP450 2C9 genotypes

SIGMA-1 Receptor Gene Variants Affect the Somatosensory Phenotype in Neuropathic Pain Patients

Impact of ABCC2 genotype on antiepileptic drug response in Caucasian patients with childhood epilepsy

Non-response to antiepileptic pharmacotherapy is associated with the ABCC2 −24C>T polymorphism in young and adult patients with epilepsy

Association of ATP-binding cassette transporter variants with the risk of Alzheimer's disease

Length variants of the

miRNA-187-3p-Mediated Regulation of the KCNK10/TREK‑2 Potassium Channel in a Rat Epilepsy Model

Expression of drug metabolizing enzymes along the human gastrointestinal tract

Suchergebnisse filtern